Natalie Groves

10.9k total citations · 1 hit paper
23 papers, 2.3k citations indexed

About

Natalie Groves is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Natalie Groves has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Natalie Groves's work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 detection and testing (6 papers). Natalie Groves is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 detection and testing (6 papers). Natalie Groves collaborates with scholars based in United Kingdom, Australia and Czechia. Natalie Groves's co-authors include Jamie Lopez Bernal, Meera Chand, Nick Andrews, Mary Ramsay, Julia Stowe, Gavin Dabrera, Eileen Gallagher, Simon Thelwall, Richard Myers and Susan Hopkins and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Infectious Diseases.

In The Last Decade

Natalie Groves

20 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

2021 1.7k citations Jamie Lopez Bernal, Nick Andrews et al. New England Journal of Medicine profile →

Peers

Natalie Groves

HEALT

EPIDE

Simon Thelwall United Kingdom

Sharon Alroy‐Preis Israel

Elise Tessier United Kingdom

Farid Khan United States

Tal Patalon Israel

Sivan Gazit Israel

Oliver J. Watson United Kingdom

Victoria Indenbaum Israel

Samuel M. S. Cheng Hong Kong

Gabriel Mircus Israel

Simon Thelwall United Kingdom

Natalie Groves

1.9k ×1.1

608 ×0.9

HEALT

581 ×1.0

247 ×0.6

172 ×0.8

EPIDE

Citations per year, relative to Natalie Groves Natalie Groves (= 1×) peers Simon Thelwall

Countries citing papers authored by Natalie Groves

Since Specialization

Citations

This map shows the geographic impact of Natalie Groves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Groves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Groves more than expected).

Fields of papers citing papers by Natalie Groves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Groves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Groves. The network helps show where Natalie Groves may publish in the future.

Co-authorship network of co-authors of Natalie Groves

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Groves. A scholar is included among the top collaborators of Natalie Groves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Groves. Natalie Groves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuch, Alicja, Ewa Sadowy, Waleria Hryniewicz, et al.. (2025). Changes in the Streptococcus pneumoniae population responsible for invasive disease of young children after the implementation of conjugated vaccines in the National Immunization Program in Poland. Vaccine. 64. 127759–127759.

Colquhoun, Rachel, Áine O’Toole, Verity Hill, et al.. (2024). A phylogenetics and variant calling pipeline to support SARS-CoV-2 genomic epidemiology in the UK. Virus Evolution. 10(1). veae083–veae083.

Twohig, Katherine A., Katie Harman, Asad Zaidi, et al.. (2023). Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection. Epidemiology and Infection. 151. e169–e169. 1 indexed citations

Kirsebom, Freja, Katie Harman, Nick Andrews, et al.. (2023). Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England. The Lancet Regional Health - Europe. 35. 100755–100755. 15 indexed citations

Harman, Katie, Sophie Nash, Harriet Webster, et al.. (2023). Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England. Influenza and Other Respiratory Viruses. 17(5). e13150–e13150. 14 indexed citations

Sinnathamby, Mary, Asad Zaidi, Katherine A. Twohig, et al.. (2023). Descriptive epidemiology of SARS‐CoV‐2 Beta (B.1.351) variant cases in England, December 2020 to June 2022. Influenza and Other Respiratory Viruses. 17(11). e13204–e13204. 1 indexed citations

Nyberg, Tommy, Katie Harman, Asad Zaidi, et al.. (2022). Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages. The Journal of Infectious Diseases. 226(5). 808–811. 6 indexed citations

Sheppard, Carmen, Sam Manna, Natalie Groves, et al.. (2022). PneumoKITy: A fast, flexible, specific, and sensitive tool for Streptococcus pneumoniae serotype screening and mixed serotype detection from genome sequence data. Microbial Genomics. 8(12). 13 indexed citations

Webster, Harriet, Tommy Nyberg, Mary Sinnathamby, et al.. (2022). Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England. Nature Communications. 13(1). 6053–6053. 18 indexed citations

10.

Kirsebom, Freja, Nick Andrews, Julia Stowe, et al.. (2022). Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England. The Lancet Regional Health - Europe. 23. 100537–100537. 22 indexed citations

11.

Kirsebom, Freja, Nick Andrews, Julia Stowe, et al.. (2022). COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England. The Lancet Infectious Diseases. 22(7). 931–933. 106 indexed citations

12.

Amin‐Chowdhury, Zahin, Natalie Groves, Carmen Sheppard, et al.. (2021). Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes. Vaccine. 39(14). 1997–2004. 15 indexed citations

13.

Richards, Peter, Katie L. Hopkins, Katherine Russell, et al.. (2021). Case Report: Toxigenic Corynebacterium ulcerans Diphtheria-Like Infection in a Horse in the United Kingdom. Frontiers in Veterinary Science. 8. 650238–650238. 2 indexed citations

14.

Allen, Hester, Amoolya Vusirikala, Joe Flannagan, et al.. (2021). Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study. The Lancet Regional Health - Europe. 12. 100252–100252. 131 indexed citations

15.

Bernal, Jamie Lopez, Nick Andrews, Charlotte Gower, et al.. (2021). Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. New England Journal of Medicine. 385(7). 585–594. 1738 indexed citations breakdown →

16.

Sharma, Himanshu, Derren Ready, J. Coelho, et al.. (2019). Real-time whole genome sequencing to control a Streptococcus pyogenes outbreak at a national orthopaedic hospital. Journal of Hospital Infection. 103(1). 21–26. 9 indexed citations

17.

Cowell, John K., Natalie Groves, & Paul N. Baird. (1993). Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene. British Journal of Cancer. 67(6). 1259–1261. 10 indexed citations

18.

Baird, Paul N., et al.. (1992). Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Human Molecular Genetics. 1(5). 301–305. 93 indexed citations

19.

Baird, Paul N., et al.. (1992). Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.. PubMed. 7(11). 2141–9. 67 indexed citations

20.

Groves, Natalie, Paul N. Baird, Annette Hogg, & John K. Cowell. (1992). A single base pair polymorphism in the WT1 gene detected by single-strand conformation polymorphism analysis. Human Genetics. 90(4). 440–2. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact